NorthWest Biotherapeutics Inc (NWBO)

[Fireman02360]

Do you have hard data to back up this kind of valuation?

Number of GBM patients vs. cost of treatment per year vs. cost of manufacturing? This would give us a great idea of what the true revenue would be. If anyone has done this please share. There seems to be some astute investors here so maybe someone has put together some numbers already.

I have not the faintest idea myself, but before I would agree I would need to see some hard data that would justify this kind of valuation.

Some also have arguing that DCvax could treat all solid cancer. That may be the case but it would take a considerable amount of money and time, and in the end could very well fail. So for now I am sticking to valuations that are based on GBM and GBM alone, as we have hard data and evidence that it does work and will be a success. Dont get me wrong, I hope your correct as I have some major skin in the game, but as I have stated several times, what retail thinks is a good valuation on a BO, almost always doesn't reflect the final offer from the acquirer.

Either way, lets hope for some good news soon. GL to all.

-Fireman